MRT 8401: Care Management Population and Benefit Expansion, Access to Services, and Consumer Rights
Transition of Coverage from Medicaid Fee-for-Service to Medicaid Managed Care
See MRT 1458 for More Information on Managed Care Transitions
Harm Reduction Services
- Harm Reduction Billing Guidance - Updated 2.25.22
- Harm Reduction Counseling Providers: Syringe Exchange Providers (SEPs) - Updated 03.04.19
- Harm Reduction Services Guidance Paper - 7.1.18
- Harm Reduction - Questions and Answers - 7.1.18
- Handbook Language - 7.1.18
- Member Notice - 7.1.18
School-Based Health Center Services - Benefit Transition Date no sooner than April 1, 2024
- SBHC Letter - 1.7.19
- Gap Report Template
- Gap Report Instructions
- Gap Report FAQ
- Policy for the Protection of Confidential Health Information for Minors Enrolled in NYS Medicaid Managed Care Plans
- SBHC Transition Milestones
- New York State Mainstream Medicaid Managed Care and School Based Health Center Billing Guidance
- FQHC Rate Schedule
- FQHC's Opting In To APG
- FAQs
- 2021 Implementation of Transition
July 1, 2017 Benefit Transition - Blood Clotting Factor
- Clotting Factor Guidelines
- Criteria Standards for Authorization & Utilization Management of Clotting Factor Products and Services for Medicaid Managed Care
- FAQs - Transition of Clotting Factor Products and Services into Medicaid Managed Care
- Reimbursement Process for Transition of Clotting Factor Products Into Medicaid Managed Care
- Active Clotting Factor Products as of 3-6-17 by:
- Clotting Factor Providers
- Hemophilia Treatment Centers (HTC)
- Clotting Disorder Individual Service Plan (PDF)
- Clotting Factor Person Centered Services Planning (PCSP) Flowcharts:
- Update: Blood Factor Carve-In
Follow Us